Cannabinoid receptor 2 expression in human proximal tubule cells is regulated by albumin independent of ERK1/2 signaling

Cellular Physiology and Biochemistry

Volumn 32, Issue 5, 2013, Pages 1309-1319

  Jenkin, Kayte A ^a   McAinch, Andrew J ^a   Briffa, Jessica F ^a,b   Zhang, Yuan ^c   Kelly, Darren J ^c   Pollock, Carol A ^d   Poronnik, Philip ^e   Hryciw, Deanne H ^a,b  

^a School of Psychology Victoria University   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cannabinoid receptor CB2; Diabetic nephropathy; Proximal tubule

Indexed keywords

ALBUMIN; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR 2; GLUCOSE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN; PROTEIN KINASE B; STREPTOZOCIN; UNCLASSIFIED DRUG; LATRUNCULIN A;

ALBUMIN BLOOD LEVEL; ALBUMINURIA; ANIMAL EXPERIMENT; ARTICLE; CELL LYSATE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; KIDNEY CELL; KIDNEY PROXIMAL TUBULE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL CELL; ANIMAL MODEL; KIDNEY TUBULE CELL; PODOCYTE; REGULATORY MECHANISM;

ANIMALIA; RATTUS;

ALBUMINS; ANIMALS; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE; HUMANS; KIDNEY TUBULES, PROXIMAL; MALE; MAP KINASE SIGNALING SYSTEM; PODOCYTES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB2; SIGNAL TRANSDUCTION;

EID: 84890679220     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000354529     Document Type: Article

References (32)

1. Vallon V: The proximal tubule in the pathophysiology of the diabetic kidney. Am J Physiol-Regul Integr Comp Physiol 2011;300:R1009-R1022.
2. Barutta F, Piscitelli F, Pinach S, Bruno G, Gambino R, Rastaldi MP, Salvidio G, Di Marzo V, Cavallo Perin P, Gruden G: Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy. Diabetes 2011;60:2386-2396.
3. Qi W, Chen X, Poronnik P, Pollock CA: Transforming growth factor-b/connective tissue growth factor axis in the kidney. Int J Biochem Cell Biol 2008;40:9-13.
4. Comper WD, Hilliard LM, Nikolic-Paterson DJ, Russo LM: Disease-dependent mechanisms of albuminuria. Am J Physiol-Renal Physiol 2008;295:F1589.
5. Jenkin KA, Verty ANA, McAinch AJ, Hryciw DH: Endocannabinoids and the renal proximal tubule: An emerging role in diabetic nephropathy. Int J Biochem Cell Biol 2012;44:2028-2031.
6. Barutta F, Corbelli A, Mastrocola R, Gambino R, Di Marzo V, Pinach S, Rastaldi M, Perin P, Gruden G: Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy. Diabetes 2010;59:1046-1054.
7. Mukhopadhyay P, Pan H, Rajesh M, Bátkai S, Patel V, Harvey-White J, Mukhopadhyay B, Haska G, Gao B, Mackie K: CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model. Br J Pharmacol 2010;160:657-668.
8. Mukhopadhyay P, Rajesh M, Pan H, Patel V, Mukhopadhyay B, Bátkai S, Gao B, Hasko G, Pacher P: Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy. Free Radic Biol Med 2010;48:457-467.
9. Muccioli GG: Endocannabinoid biosynthesis and inactivation, from simple to complex. Drug Discov Today 2010;15:474-483.
10. Di Marzo V: The endocannabinoid system in obesity and type 2 diabetes. Diabetologia 2008;51:1356-1367.
11. Janiak P, Poirier B, Bidouard J, Cadrouvele C, Pierre F, Gouraud L, Barbosa I, Dedio J, Maffrand J, Le Fur G: Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats. Kidney Int 2007;72:1345-1357.
12. Lim JC, Lim SK, Han HJ, Park SH: Cannabinoid receptor 1 mediates palmitic acid-induced apoptosis via endoplasmic reticulum stress in human renal proximal tubular cells. J Cell Physiol 2010;225:654-663.
13. Pacher P, Mechoulam R: Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog Lipid Res 2011;50:193-211.
14. Christensen EI, Verroust PJ: Interstitial fibrosis: tubular hypothesis versus glomerular hypothesis. Kidney Int 2008;74:1233-1236.
15. Rane MJ, Song Y, Jin S, Barati MT, Wu R, Kausar H, Tan Y, Wang Y, Zhou G, Klein JB: Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy. Am J Physiol-Renal Physiol 2010;298:F49-F61.
16. Nishimoto S, Nishida E. MAPK signalling: ERK5 versus ERK1/2. EMBO rep 2006;7:782-786.
17. Feliers D, Kasinath BS: Erk in kidney diseases. J Signal Transduct 2011;2011:768512.
18. Correa F, Docagne F, Mestre L, Clemente D, Hernangómez M, Loría F, Guaza C: A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells. Biochem Pharmacol 2009;77:86-100.
19. Romero-Sandoval EA, Horvath R, Landry RP, DeLeo JA: Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation. Mol Pain 2009;5:25-40.
20. Phillips A, Steadman R: Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury. Histol Histopathol 2002;17:247-252.
21. Jenkin KA, McAinch AJ, Grinfeld E, Hryciw DH: Role for Cannabinoid Receptors in Human Proximal Tubular Hypertrophy. Cell Physiol Biochem 2010;26:879-886.
22. Zafiriou S, Stanners SR, Polhill TS, Poronnik P, Pollock CA: Pioglitazone increases renal tubular cell albumin uptake but limits proinflammatory and fibrotic responses. Kidney Int 2004;65:1647-1653.
23. Hryciw D, Pollock C, Poronnik P: PKCa mediated remodeling of the actin cytoskeleton is involved in constitutive albumin uptake by proximal tubule cells. Am J Physiol-Renal Physiol 2005;288:F1227.
24. 2+ signals and insulin secretion in pancreatic β-cell. Cell Calcium 2006;39:155-162.
25. Christensen E, Verroust P, Nielsen R: Receptor-mediated endocytosis in renal proximal tubule. Pflügers Archiv 2009;458:1039-1048.
26. Cabral G, Griffin-Thomas L: Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects. Expert Rev Mol Med 2010;11:e3.
27. Tanasescu R, Constantinescu CS: Cannabinoids and the immune system: An overview. Immunobiol 2010;215:588-597
28. Lim AKH, Tesch GH: Inflammation in Diabetic Nephropathy. Mediators Inflamm 2012:2012:146154.
29. Horváth B, Mukhopadhyay P, Kechrid M, Patel V, Tanchian G, Wink DA, Gertsch J, Pacher P: β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner. Free Radic Biol Med 2012;52:1325-1331.
30. Tang SCW, Lai KN: The pathogenic role of the renal proximal tubular cell in diabetic nephropathy. Nephrol Dial Transplant 2012;27:3049-3056.
31. Gardner B, Zu LX, Sharma S, Liu Q, Makriyannis A, Tashkin DP, Dubinett SM: Autocrine and Paracrine Regulation of Lymphocyte CB2 Receptor Expression by TGF-β. Biochem Biophys Res Comm 2002;290:91-96.
32. Lakshmanan AP, Thandavarayan RA, Watanabe K, Sari FR, Meilei H, Giridharan VV, Sukumaran V, Soetikno V, Arumugam S, Suzuki K: Modulation of at-1r/mapk cascade by an olmesartan treatment attenuates diabetic nephropathy in streptozotocin-induced diabetic mice. Mol Cell Endocrinol 2012;348:104-111.